Evidence map›Paper›PMID 29235497›Full record

ArticleScientific reports2017

Pharmacological modulation of Kv3.1 mitigates auditory midbrain temporal processing deficits following auditory nerve damage.

Anna R Chambers, Nadia Pilati, Pooja Balaram, Charles H Large, Leonard K Kaczmarek, Daniel B Polley

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. KFrontiers in pharmacology · 2026
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Electrophysiological and Psychophysical Measures of Temporal Pitch Sensitivity in Normal-hearing Listeners.Journal of the Association for Research in Otolaryngology : JARO · 2023
    Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Sparsely Distributed, Pre-synaptic Kv3 KFrontiers in cellular neuroscience · 2021
    Article
  16. Distribution of KExperimental neurobiology · 2020
    Article
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Anna R ChambersEaton-Peabody Laboratories, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Nadia PilatiAutifony SRL, Verona, Italy; and Autifony Therapeutics Limited, Imperial College Incubator, London, UK.
Pooja BalaramEaton-Peabody Laboratories, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
Charles H LargeAutifony SRL, Verona, Italy; and Autifony Therapeutics Limited, Imperial College Incubator, London, UK.
Leonard K KaczmarekDepartments of Pharmacology and Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA.
Daniel B PolleyEaton-Peabody Laboratories, Massachusetts Eye and Ear Infirmary, Boston, MA, USA. daniel.polley@epl.meei.harvard.edu.
Autifony Therapeutics (United Kingdom) · GBMassachusetts Eye and Ear Infirmary · USHarvard University · USYale University · US

Funding

EXPRESSION OF ION CHANNELS IN THE AUDITORY SYSTEMR01DC001919 · NIDCD · YALE UNIVERSITY · PI KACZMAREK, LEONARD K · 1993 to 2025
$9.7M
Activity-Dependent Influences on Auditory CircuitsR01DC009836 · NIDCD · VANDERBILT UNIVERSITY · PI POLLEY, DANIEL B. · 2009 to 2024
$6.7M
NIDCD NIH HHS R01 DC001919NIDCD NIH HHS R01 DC009836
6 · The paper itself

Abstract

Higher stages of central auditory processing compensate for a loss of cochlear nerve synapses by increasing the gain on remaining afferent inputs, thereby restoring firing rate codes for rudimentary sound features. The benefits of this compensatory plasticity are limited, as the recovery of precise temporal coding is comparatively modest. We reasoned that persistent temporal coding deficits could be ameliorated through modulation of voltage-gated potassium (Kv) channels that regulate temporal firing patterns. Here, we characterize AUT00063, a pharmacological compound that modulates Kv3.1, a high-threshold channel expressed in fast-spiking neurons throughout the central auditory pathway. Patch clamp recordings from auditory brainstem neurons and in silico modeling revealed that application of AUT00063 reduced action potential timing variability and improved temporal coding precision. Systemic injections of AUT00063 in vivo improved auditory synchronization and supported more accurate decoding of temporal sound features in the inferior colliculus and auditory cortex in adult mice with a near-complete loss of auditory nerve afferent synapses in the contralateral ear. These findings suggest modulating Kv3.1 in central neurons could be a promising therapeutic approach to mitigate temporal processing deficits that commonly accompany aging, tinnitus, ototoxic drug exposure or noise damage.

Indexed as

Action PotentialsAnimalsAuditory PathwaysAuditory PerceptionCochlear NerveCompulsive BehaviorDisease Models, AnimalImidazolesMembrane Transport ModulatorsMesencephalonMiceModels, BiologicalNeuronsOuabainPyrimidinesRecovery of FunctionAUT00063ImidazolesKcnc1 protein, mouseMembrane Transport ModulatorsOuabainPyrimidinesShaw Potassium Channels

Identifiers

PMID29235497
PMCPMC5727503
OpenAlexW2773571213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.